No Detail Found!

Prophylactic vs therapeutic blood transfusions impact on pregnant sickle cell patients

Author(s)
Ifat Imran College of Medicine, Taif University, Taif, Saudi Arabia.
Imran Nazir University Medical and Dental College, Faisalabad, Pakistan
Rakan Tariq J Al Rfaai Security Forces Hospital Makkah, Makkah, Saudi Arabia
Khalid Khalil Security Forces Hospital Makkah, Makkah, Saudi Arabia
Abstract
Objective: To observe the fetomaternal outcome of therapeutic versus prophylactic blood transfusions in patients with sickle cell disease (SCD) during pregnancy. Method: This single-center retrospective observational study was conducted on consecutive pregnant women with SCD between January 2018 and December 2020. All the pregnant women with SCD were included in this study. Sickler women carrying sickle cell traits (HbAS, HbAC), multiple pregnancy, or other medical diseases were excluded from the study. We used non-random, convenience sampling and collected their demographic details, medical history, course of SCD before & during pregnancy, maternal/fetal outcome, laboratory parameters, and other information using the questionnaire. Patients were sub-grouped into three according to blood transfusion categories (therapeutic, prophylactic, or not transfused) during the pregnancy. Descriptive data were represented as numbers and mean ± SD values. The medical and obstetrical complications and fetomaternal outcomes among the three groups were analyzed by Chi-square/Fisher's Extract test. Results: The study included 62 patients, 37 were in the therapeutic group, 11 were in the prophylactic group, and 14 were in the non-transfusion group. Hemolytic crises, painful crises, acute chest syndrome, pregnancy-induced hypertension (PIH), preeclampsia, preterm births, intrauterine growth retardation (IUGR), and neonatal ICU admission were significantly lower among the prophylactic group (P = 0.000, p = 0.000, p = 0.001, p = 0.002, p = 0.009, p = 0.007, p =0.001 & p= 0.016 respectively) compared with other two groups. Conclusions: Our study demonstrates that prophylactic blood transfusion in SCD positively alters the course of pregnancy by reducing fetomaternal complications.
Publication Details
Page(s) 44-48
Published Journal: Pakistan Journal of Medical Sciences, Volume: 41, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Pregnancy, Blood transfusion, Sickle cell disease
References
Ware RE,De Montalembert M,Tshilolo L,Abboud MR,Piel FB,Steinberg MH,Rees DC .2017 .Sickle Cell Disease. N Engl J Med, 376(16) : 1561-1573.
Nazir I,Alharthi BA,Althomali HA,Alsini RA,Alzaedi HZ,Althagafi MA,Imran I,Bashir NZ,Fatima U,Nazir I,Khan RR .2019 .Short Inter-Pregnancy Interval as a Risk Factor for Anaemia in Pregnancy. EC Microbiol, 15(12) : 148-157.
.2020 .Correlation of different obstetrical factors with hemoglobin level in pregnant females. Prof Med, 27(3) : 625-630.
Alsaeed ES,Farhat GN,Assiri AM,Memish Z,Ahmed EM,Saeedi MY .2011 .Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program,. , 10 : 2015.
Jain D,Atmapoojya P,Colah R .2019 .. Sickle Cell Disease and Pregnancy. Mediterr J Hematol Infect Dis, 11(1) : e2019040-S47.
Burgos Luna JM,Paez Rúa DM,Ruiz Ordoñez I,Fernández PA .2020 .Description of criteria for near miss in high-complexity obstetric population with sickle cell anemia: an observational study. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet, 33(6) : 941-946.
Sharif J,Byrd L,Stevenson K,Raddats J,Morsman E,Ryan K. .2018 .Transfusion for sickle cell disease in pregnancy: a single-centre survey. Transfus Med, 28(3) : 231-235.
Tanhehco YC,Shi PA,Schwartz J. .2022 .7:9. Ann Blood, 10 : .
Fortin PM,Hopewell S,Estcourt LJ .2018 .Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews. Cochrane Database Syst Rev, 8(8) : CD012082.
Howard J .2016 .Sickle cell disease: when and how to transfuse. Hematol Am Soc Hematol Educ Progr, : 625-631.
Asma S,Kozanoglu I,Tarım E,Sarıturk C,Gereklioglu C,Akdeniz A .2015 .Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy. Transfusion, 55(1) : 36-44.
Malinowski AK,Shehata N,D'Souza R,Kuo KHM,Ward R,Shah PS .2015 .Prophylactic transfusion for pregnant women with sickle cell disease: A systematic review and meta-analysis. Blood, 126(21) : 2424-2435.
Yılmaz Baran S,Kozanoglu I,Korur A,Dogan Durdag G,Kalaycı H,Alemdaroğlu S .2021 .Role of prophylactic and therapeutic red blood cell exchange in pregnancy with sickle cell disease: Maternal and perinatal outcomes. J Clin Apher, 36(3) : 283-290.
AlMoshary M,Arabdin M. . .The role of prophylactic transfusion on the maternal and fetal outcomes in pregnant women with sickle cell disease: A systematic review and meta-analysis. 2024 Sep, 10(36) : .
Jackson B,Fasano R,Roback J .2018 .Current Evidence for the Use of Prophylactic Transfusion to Treat Sickle Cell Disease During Pregnancy. Transfus Med Rev, 06(4) : 220-224.
Okusanya BO,Oladapo OT .2016 .Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy. Cochrane database Syst Rev, 10(12) : .
Sousa VT,Ballas SK,Leite JM,Olivato MCA,Cancado RD .2022 .Maternal and perinatal outcomes in pregnant women with sickle cell disease: an update. Hematol Transfus Cell Ther, 44(3) : 369-373.
Smith-Whitley K. .2019 .Complications in pregnant women with sickle cell disease. Hematol Am Soc Hematol Educ Progr, : 359-366.
Davis BA,Allard S,Qureshi A,Porter JB,Pancham S,Win N .2017 .Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion. Br J Haematol, 176(2) : 192-209.
Kuriri FA,Ahmed A,Alanazi F,Alhumud F,Ageeli Hakami M,Atiatalla Babiker Ahmed O. Red M .2023 .1):3239960. , 10 : .
.2024 .Women's health- Sickle Cell Anemia and Pregnancy. (Cited January 04, : .
Zamané H,Sanou F,Kiemtoré S,Kain DP,Sawadogo AK .2019 .Transfusion practices in the care of pregnant women with sickle cell disease in Ouagadougou. Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet, 147(3) : 363-367.
0

Citations

0

Downloads

63

Views